Table 2.
Maternal Near-Miss Definitions and Indicators
| Terminology | Definitions |
|---|---|
| Near-miss indicators | |
| Maternal near miss (MNM) | A woman who nearly died but survived a complication that occurred during pregnancy, childbirth or within 42 days of termination of pregnancy |
| MNM ratio (MNMR) | The number of maternal near-miss cases per 1000 live births |
| Maternal mortality ratio (MMR) | The number of maternal deaths per 100,000 live births |
| Severe maternal outcome (SMO) | The sum of maternal near misses and maternal deaths |
| Severe maternal outcome ratio (SMOR) | The number of women with SMO per 1000 live births (LB). This indicator gives an estimate of the amount of care and resources that would be needed in an area or facility |
| Maternal near-miss mortality ratio (MNM: 1 MD) | The ratio between maternal near miss and maternal deaths. Higher ratios show better care |
| Mortality index | The number of maternal deaths divided by the number of women with SMO. The lower the index, the fewer women with life-threatening complications die (better quality of care) whereas the higher the index, the more women with life-threatening complications die (low quality of care) |
| Hospital access indicators | |
| SMO12 | Women presenting the organ dysfunction or maternal death (SMO) within 12 hours of hospital stay from admission |
| SMO12 mortality index | The number of women with SMO12 divided by the number of all SMO cases expressed as a percentage |
| Intrahospital access indicators | |
| SMO after 12 hrs of hospital stay 12 | Women experienced SMO after 12 hours of hospital stay |
| SMO after 12 hrs mortality index | The number of women with SMO after 12 hours of hospital stay divided by the number of all SMO cases expressed as a percentage |
| Process indicators | |
| Prevention of postpartum haemorrhage | The number of women who received a single dose of oxytocin divided by the number of all women giving birth |
| Treatment of severe postpartum haemorrhage | The number of women with severe PPH who received therapeutic oxytocin divided by the number of all women with postpartum haemorrhage. |
| Treatment sepsis | The number of women with sepsis who received IV antibiotics divided by the number of all women with sepsis |